DNA repair gene ERCC1 polymorphisms may contribute to the risk of glioma

Tumor Biology

Volumn 35, Issue 5, 2014, Pages 4267-4275

  Yuan, Guanqian ^a   Gao, Dandan ^a   Ding, Shaofeng ^a   Tan, Jun ^a  

^a GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

Author keywords

ERCC1; Glioma; Meta analysis; Polymorphisms

Indexed keywords

EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; DNA BINDING PROTEIN; ENDONUCLEASE; ERCC1 PROTEIN, HUMAN;

ALLELE; ARTICLE; CANCER RISK; COCHRANE LIBRARY; DISEASE COURSE; DNA REPAIR; EMBASE; ETHNICITY; GENETIC SUSCEPTIBILITY; GENOTYPE; GLIOBLASTOMA; GLIOMA; HUMAN; MEDLINE; META ANALYSIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; BRAIN TUMOR; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; PUBLISHING; RISK;

BRAIN NEOPLASMS; DNA-BINDING PROTEINS; ENDONUCLEASES; GENETIC PREDISPOSITION TO DISEASE; GLIOMA; HUMANS; POLYMORPHISM, GENETIC; PUBLICATION BIAS; RISK;

EID: 84902972483     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-1557-6     Document Type: Article

References (45)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225-49.
2. Louis DN, Holland EC, Cairncross JG. Glioma classification: a molecular reappraisal. Am J Pathol. 2001;159:779-86. (Pubitemid 32847166)
3. Rousseau A, Mokhtari K, Duyckaerts C. The 2007 WHO classification of tumors of the central nervous system - what has changed? Curr Opin Neurol. 2008;21:720-27.
4. Ohgaki H, Kleihues P. Epidemiology and etiology of gliomas. Acta Neuropathol. 2005;109:93-108. (Pubitemid 40287792)
5. Bondy M, Wiencke J, Wrensch M, Kyritsis AP. Genetics of primary brain tumors: a review. J Neurooncol. 1994;18:69-81. (Pubitemid 24157278)
6. Wrensch M, Lee M, Miike R, Newman B, Barger G, et al. Familial and personal medical history of cancer and nervous system conditions among adults with glioma and controls. Am J Epidemiol. 1997;145:581-93. (Pubitemid 27154860)
7. Little MP, de Vathaire F, Shamsaldin A, Oberlin O, Campbell S, et al. Risks of brain tumour following treatment for cancer in childhood: modification by genetic factors, radiotherapy and chemotherapy. Int J Cancer. 1998;78:269-75. (Pubitemid 28445359)
8. Bondy ML, Wang LE, El-Zein R, de Andrade M, Selvan MS, et al. Gamma-radiation sensitivity and risk of glioma. J Natl Cancer Inst. 2001;93:1553-57.
9. Goode EL, Ulrich CM, Potter JD. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev. 2002;11:1513-30. (Pubitemid 36020002)
10. Ronen A, Glickman BW. Human DNA repair genes. Environ Mol Mutagen. 2001;37:241-83. (Pubitemid 32411130)
11. Friedberg EC.How nucleotide excision repair protects against cancer. Nat Rev Cancer. 2001;1:22-33. (Pubitemid 33741878)
12. Zhang H, Liu H, Knauss JL. Associations between three XRCC1 polymorphisms and glioma risk: a meta-analysis. Tumour Biol. 2013;34(5):3003-13.
13. Wei X, Chen D, Lv T. A functional polymorphism in XRCC1 is associated with glioma risk: evidence from a meta-analysis.Mol Biol Rep. 2013;40:567-72.
14. Li M, Zhou Q, Tu C, Jiang Y. A meta-analysis of an association between the XRCC1 polymorphisms and gliomas risk. J Neurooncol. 2013;111:221-28.
15. Jiang L, Fang X, Bao Y, Zhou JY, Shen XY, et al. Association between the XRCC1 polymorphisms and glioma risk: a meta-analysis of case-control studies. PLoS One. 2013;8:e55597.
16. Zhang L, Wang Y, Qiu Z, Luo J, Zhou Z, et al. The XRCC1 Arg194Trp polymorphism is not a risk factor for glioma: a meta-analysis involving 1,440 cases and 2,562 controls. Exp Ther Med. 2012;4:1057-62.
17. Sun JY, Zhang CY, Zhang ZJ, Dong YF, Zhang AL, et al. Association between XRCC1 gene polymorphisms and risk of glioma development: a meta-analysis. Asian Pac J Cancer Prev. 2012;13:4783-8.
18. Jacobs DI, Bracken MB. Association between XRCC1polymorphism 399 G->A and glioma among Caucasians: a systematic review and meta-analysis. BMC Med Genet. 2012;13:97.
19. Zhao B, Ye J, Li B, Ma Q, Su G, et al. DNA repair gene XRCC3 Thr241Met polymorphism and glioma risk: a meta-analysis. Int J Clin Exp Med. 2013;6:438-43.
20. Lin J, Kou Y. Association between the Thr241Met polymorphism of X-ray repair cross-complementing group 3 gene and glioma risk: evidence from a meta-analysis based on 4,136 cases and 5,233 controls. Tumour Biol. 2013.
21. Jiang J, Quan XF, Zhang L, Wang YC. The XRCC3 Thr241Met polymorphism influences glioma risk - a meta-analysis. Asian Pac J Cancer Prev. 2013;14:3169-73.
22. Liu Y, Zhou K, Zhang H, Shugart YY, Chen L, et al. Polymorphisms of LIG4 and XRCC4 involved in the NHEJ pathway interact to modify risk of glioma. Hum Mutat. 2008;29:381-9. (Pubitemid 351364940)
23. Liu Y, Zhang H, Zhou K, Chen L, Xu Z, et al. Tagging SNPs in non-homologous end-joining pathway genes and risk of glioma. Carcinogenesis. 2007;28:1906-13. (Pubitemid 47500602)
24. Sijbers AM, de Laat WL, Ariza RR, Biggerstaff M, Wei YF, et al. Xeroderma pigmentosum group F caused by a defect in a structure-specific DNA repair endonuclease. Cell. 1996;86:811-22. (Pubitemid 26303449)
25. Smith JS, Tachibana I, Pohl U, Lee HK, Thanarajasingam U, et al. A transcript map of the chromosome 19q-arm glioma tumor suppressor region. Genomics. 2000;64:44-50. (Pubitemid 30165073)
26. Chen P, Wiencke J, Aldape K, Kesler-Diaz A, Miike R, et al. Association of an ERCC1 polymorphism with adult-onset glioma. Cancer Epidemiol Biomarkers Prev. 2000;9:843-47. (Pubitemid 30660059)
27. Liu Y, Scheurer ME, El-Zein R, Cao Y, Do KA, et al. Association and interactions between DNA repair gene polymorphisms and adult glioma. Cancer Epidemiol Biomarkers Prev. 2009;18:204-14.
28. Pan WR, Li G, Guan JH. Polymorphisms in DNA repair genes and susceptibility to glioma in a Chinese population. Int J Mol Sci. 2013;14:3314-24.
29. da Costa BR, Cevallos M, Altman DG, Rutjes AW, Egger M. Uses and misuses of the STROBE statement: bibliographic study. BMJ Open. 2011;1:e000048.
30. Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet. 1955;19:251-53.
31. Jackson D, White IR, Riley RD. Quantifying the impact of between-study heterogeneity in multivariate meta-analyses. Stat Med. 2012;31:3805-20.
32. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Comparison of two methods to detect publication bias in meta-analysis. JAMA. 2006;295:676-80. (Pubitemid 43209069)
33. Zintzaras E, Ioannidis JP. Heterogeneity testing in meta-analysis of genome searches. Genet Epidemiol. 2005;28:123-37.
34. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test.BMJ. 1997;315:629-34. (Pubitemid 27387172)
35. Wrensch M, Kelsey KT, Liu M, Miike R, Moghadassi M, et al. ERCC1 and ERCC2 polymorphisms and adult glioma. Neuro Oncol. 2005;7:495-507. (Pubitemid 41555621)
36. McKean-Cowdin R, Barnholtz-Sloan J, Inskip PD, Ruder AM, Butler M, et al. Associations between polymorphisms in DNA repair genes and glioblastoma. Cancer Epidemiol Biomarkers Prev. 2009;18:1118-26.
37. Chen DQ, Yao DX, Zhao HY, Yang SJ. DNA repair gene ERCC1 and XPD polymorphisms predict glioma susceptibility and prognosis. Asian Pac J Cancer Prev. 2012;13:2791-94.
38. Zhang N, Lin LY, Zhu LL, Wu F, Wen H, et al. ERCC1 polymorphisms and risk of adult glioma in a Chinese population: a hospital-based case-control study. Cancer Invest. 2012;30:199-202.
39. Luo KQ, Mu SQ, Wu ZX, Shi YN, Peng JC. Polymorphisms in DNA repair genes and risk of glioma and meningioma. Asian Pac J Cancer Prev. 2013;14:449-52.
40. Ricard D, Idbaih A, Ducray F, Lahutte M, Hoang-Xuan K, et al. Primary brain tumours in adults. Lancet. 2012;379:1984-96.
41. Schwartzbaum JA, Fisher JL, Aldape KD, Wrensch M. Epidemiology and molecular pathology of glioma. Nat Clin Pract Neurol. 2006;2:494-503. (Pubitemid 44275725)
42. Wood RD, Mitchell M, Sgouros J, Lindahl T. Human DNA repair genes. Science. 2001;291:1284-89. (Pubitemid 32173086)
43. Berwick M, Vineis P. Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J Natl Cancer Inst. 2000;92:874-97. (Pubitemid 30429188)
44. Ron E, Modan B, Boice Jr JD, Alfandary E, Stovall M, et al. Tumors of the brain and nervous system after radiotherapy in childhood. N Engl J Med. 1988;319:1033-39.
45. Tsang RW, Laperriere NJ, Simpson WJ, Brierley J, Panzarella T, et al. Glioma arising after radiation therapy for pituitary adenoma. A report of four patients and estimation of risk. Cancer. 1993;72:2227-33. (Pubitemid 23280152)